Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 177

1.

Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature.

Laurin LP, Nachman PH, Foster BJ.

Can J Kidney Health Dis. 2017 Feb 22;4:2054358117692559. doi: 10.1177/2054358117692559. eCollection 2017 Feb 22. Review.

2.

Endocytic Trafficking at the Mature Podocyte Slit Diaphragm.

Swiatecka-Urban A.

Front Pediatr. 2017 Feb 24;5:32. doi: 10.3389/fped.2017.00032. Review.

3.

Recent advances in understanding and treating nephrotic syndrome.

Bierzynska A, Saleem M.

F1000Res. 2017 Feb 9;6:121. doi: 10.12688/f1000research.10165.1. Review.

4.

Dyslipidemia in patients with chronic kidney disease: etiology and management.

Mikolasevic I, ┼Żutelija M, Mavrinac V, Orlic L.

Int J Nephrol Renovasc Dis. 2017 Feb 7;10:35-45. doi: 10.2147/IJNRD.S101808. Review.

5.

Primary Coenzyme Q10 Deficiency.

Salviati L, Trevisson E, Doimo M, Navas P.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2017 Jan 26.

6.

Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis.

Yin S, He T, Li Y, Wang J, Zeng W, Tang S, Zhao J.

Medicine (Baltimore). 2016 Dec;95(50):e5320. Review.

7.

[Advances in clinical research on C1q nephropathy].

Yang J, Zhang BL.

Zhongguo Dang Dai Er Ke Za Zhi. 2016 Nov;18(11):1194-1198. Review. Chinese.

8.

Lichen Planus Pigmentosus: The Controversial Consensus.

Ghosh A, Coondoo A.

Indian J Dermatol. 2016 Sep-Oct;61(5):482-6. doi: 10.4103/0019-5154.190108. Review.

9.

Rituximab in Membranous Nephropathy: Not All Studies Are Created Equal.

Cravedi P.

Nephron. 2017;135(1):46-50. doi: 10.1159/000450659. Review.

10.

Actualizing the Benefits of Genomic Discovery in Pediatric Nephrology.

Sampson MG.

J Pediatr Genet. 2016 Mar;5(1):69-75. doi: 10.1055/s-0035-1557113. Review.

11.

The Genetics of Nephrotic Syndrome.

Rheault MN, Gbadegesin RA.

J Pediatr Genet. 2016 Mar;5(1):15-24. doi: 10.1055/s-0035-1557109. Review.

12.

Management of Membranous Nephropathy in Western Countries.

Alfaadhel T, Cattran D.

Kidney Dis (Basel). 2015 Sep;1(2):126-37. doi: 10.1159/000437287. Review.

13.

Management of Membranous Nephropathy in Asia.

Xu J, Hu X, Xie J, Chen N.

Kidney Dis (Basel). 2015 Sep;1(2):119-25. doi: 10.1159/000437288. Review.

14.

Elucidating novel disease mechanisms in severe asthma.

Kim RY, Rae B, Neal R, Donovan C, Pinkerton J, Balachandran L, Starkey MR, Knight DA, Horvat JC, Hansbro PM.

Clin Transl Immunology. 2016 Jul 15;5(7):e91. doi: 10.1038/cti.2016.37. Review.

15.

Rapidly Progressive Glomerulonephritis in Autosomal Dominant Polycystic Kidney Disease.

Hasan AAA, Makary R, James LR.

In: Li X, editor. Polycystic Kidney Disease [Internet]. Brisbane (AU): Codon Publications; 2015 Nov. Chapter 20.

16.

Renal biopsy: Still a landmark for the nephrologist.

Visconti L, Cernaro V, Ricciardi CA, Lacava V, Pellican├▓ V, Lacquaniti A, Buemi M, Santoro D.

World J Nephrol. 2016 Jul 6;5(4):321-7. doi: 10.5527/wjn.v5.i4.321. Review.

17.

FSGS: Diagnosis and Diagnostic Work-Up.

Sprangers B, Meijers B, Appel G.

Biomed Res Int. 2016;2016:4632768. doi: 10.1155/2016/4632768. Review.

18.

Nephrotic syndrome-induced thromboembolism in adults.

Al-Azzawi HF, Obi OC, Safi J, Song M.

Int J Crit Illn Inj Sci. 2016 Apr-Jun;6(2):85-8. doi: 10.4103/2229-5151.183019. Review.

19.

History of Nephrotic Syndrome and Evolution of its Treatment.

Pal A, Kaskel F.

Front Pediatr. 2016 May 30;4:56. doi: 10.3389/fped.2016.00056. Review.

20.

Infection-Related Focal Segmental Glomerulosclerosis in Children.

Dettmar AK, Oh J.

Biomed Res Int. 2016;2016:7351964. doi: 10.1155/2016/7351964. Review.

Supplemental Content

Loading ...
Support Center